Literature DB >> 8221782

Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen.

K E Airaksinen1, P I Salmela, M K Linnaluoto, M J Ikäheimo, K Ahola, L J Ryhänen.   

Abstract

OBJECTIVE: Non-enzymatic glycosylation of proteins occurs in diabetes and advanced glycosylated end products can accumulate in long lived proteins such as vascular collagen and reduce the elasticity of vessel walls. To evaluate the potential association of advanced glycosylated end products in collagen with diminished arterial elasticity in diabetes, 14 diabetic and 14 age and sex matched non-diabetic patients with coronary artery disease were studied.
METHODS: Arterial elasticity was assessed in terms of carotid to femoral pulse wave velocity and by measuring the change in ascending aortic diameter induced by pulse pressure. Collagen linked fluorescence, a measure of advanced glycosylated end products, was determined from tissue specimens of the skin, ascending aorta, and right atrial appendage taken during coronary bypass surgery.
RESULTS: As a sign of diminished arterial elasticity, carotid to femoral pulse wave velocity was raised (p < 0.01) and change in ascending aortic diameter tended to be diminished (p = 0.09) in the diabetic patients. Collagen linked fluorescence was increased (p < 0.05) in the myocardium of the diabetic group, but the difference in skin and aorta was not significant. Collagen linked fluorescence between the aorta, skin, and myocardium correlated with each other (r = 0.64-0.77). Collagen linked fluorescence in the aorta and myocardium correlated with carotid to femoral pulse wave velocity (r = 0.63 and r = 0.67, respectively) in the diabetic group but not in the control group.
CONCLUSIONS: These data suggest that non-enzymatic glycosylation of matrix proteins, and specifically collagen, may modify arterial elasticity in diabetic patients with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221782     DOI: 10.1093/cvr/27.6.942

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  28 in total

Review 1.  Biomechanics of the cardiovascular system: the aorta as an illustratory example.

Authors:  Ghassan S Kassab
Journal:  J R Soc Interface       Date:  2006-12-22       Impact factor: 4.118

Review 2.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.

Authors:  C D A Stehouwer; R M A Henry; I Ferreira
Journal:  Diabetologia       Date:  2008-02-01       Impact factor: 10.122

4.  Impact of systemic hypertension on the assessment of aortic stenosis.

Authors:  L Kadem; J G Dumesnil; R Rieu; L-G Durand; D Garcia; P Pibarot
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

5.  Impact of the metabolic syndrome on aortic pulse pressure and ascending aortic pulsatility in patients with angiographically normal coronary arteries.

Authors:  Ayse Emre; Dilaver Oz; Kemal Yesilcimen; Nurten Sayar; Dilek Ergun
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

6.  The role of glycation cross-links in diabetic vascular stiffening.

Authors:  T J Sims; L M Rasmussen; H Oxlund; A J Bailey
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

7.  Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

Authors:  B H Wolffenbuttel; C M Boulanger; F R Crijns; M S Huijberts; P Poitevin; G N Swennen; S Vasan; J J Egan; P Ulrich; A Cerami; B I Lévy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 8.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 9.  Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease.

Authors:  Susan J Zieman; David A Kass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.